12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

12/2024

Dec 21, 2024, 10:35 | Insight
30 Years of Leadership in Immuno-Oncology - Agenus
Agenus shared on LinkedIn: “For 30 years, we have been at the forefront of immuno-oncology.…
Dec 21, 2024, 10:19 | Blog
A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil
Germline Pathogenic Variants in High and Moderate Penetrance Breast Cancer Genes in Brazil Breast cancer…
Dec 21, 2024, 10:09 | Dialogues
Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market
Interview with Mikhail Groubman, By the Editor-in-Chief of OncoDaily, Gevorg Tamamyan Mikhail Groubman is the…
Dec 21, 2024, 09:22 | Blog
When the world of science and sports comes together! - The V Foundation
The V Foundation posted on LinkedIn: "We love when the world of science and sports…
Dec 21, 2024, 09:16 | Blog
Timely cancer treatment isn’t just a goal, It’s a necessity - European Cancer Organisation
European Cancer Organisation posted on LinkedIn: "Timely cancer treatment isn’t just a goal. It’s a…
Dec 21, 2024, 09:06 | Science
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute,…
Dec 21, 2024, 09:00 | Blog
Miriam Mutebi: Does Nipple and Areola Size Matter?
Miriam Mutebi, Assistant Professor in the Department of Surgery at the Aga Khan University Hospital…
Dec 21, 2024, 08:57 | Blog
Vincent Rajkumar: A good motto in medicine is See one, Do one, Teach one
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, posted on X:…
Dec 21, 2024, 08:51 | Science
Wafik S. El-Deiry: A recent review on Targeting the SMURF2-HIF1α axis
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, posted…
Dec 21, 2024, 08:48 | Science
Oncology Brothers: Another ALK inhibitor gets FDA approval
Oncology Brothers posted on X: "Another ALK inhibitor (ensartinib) gets FDA approval eXalt3 study: 1L,…
All: 2613 Posts: 791 - 800
Special Coverage